All of humanity is today immersed in a global pandemic. Since the beginning of the COVID–19 emergency, our collective future has been rapidly accelerated, and we must respond with a strong capacity for action to reinvent the many processes to which we had become accustomed and which today have suddenly become obsolete.
Smart working is quickly becoming the rule, rather than the exception, in small and large companies alike. Simultaneously, healthcare is also rapidly becoming Smart: we seldomly attend doctors’ offices and avoid trips to the hospital whenever possible.
Nevertheless, we need now, more than ever, greater accessibility to tools that allow us to personally assess our state of health and, in particular, the health of our lungs and overall respiratory function.
MIR – Medical International Research is making its most innovative technology available to healthcare professionals and their patients in the pneumology sector by pairing a series of new, reliable, and ready–to–use smartphone–compatible Smart devices with its professional line of products to help facilitate more comprehensive personal health monitoring.
For a company, nothing says "reality check" like such an impetuous change in market needs. It is for this reason that today we invite you to discover the competitive advantage of our products which directly align with the rapidly growing global mega–trend of new public–private and home healthcare models.
National Health Services (NHS) – forced to change its governance of new products and services as a result of evolving digital communication protocols – appreciated MIR’s multisensor capabilities which helped them to quickly and easily implement our products into their virtual home visit procedures. In particular, NHS discovered SPIROBANK OXI, a brand new and highly accurate product that seemlessly integrates a spirometer with a touch pulse oximeter and a digital reflectance SpO2 sensor.
We now know that after recovering from a COVID–19 infection, the lungs are still at increased risk for at least 6 months and 30% of recovered patients may ultimately develop future chronic respiratory problems – this constitutes a serious new health emergency. In this worrying scenario, portable MIR devices have become invaluable strategic tools that have been rapidly integrated into multiple countries’ comprehensive health systems to help manage this emergency.
Pneumological teams that are responsible for studying the ever–growing number of patients undergoing rehabilitation, respiratory physiotherapy and clinical monitoring have found our products and solutions to be greatly helpful in this demanding work.
Will those who have recovered from this serious illness ever return to normal physical activity? Will their quality of life be affected long after the illness has passed? When can they return to work? Our proprietary 6 minute walking test (6MWT) can provide helpful answers to these questions and more. MIR is internationally recognized for the uniqueness of our patented products such as Spirodoc used in running the 6MWT with a 3D oximeter: %SpO2 measurement integrated with a triaxial accelerometer.
At MIR, we have spent years developing and honing our product mix and we believe this allows us to offer a wide range of instruments that perfectly address the growing need for diagnostic tools and, together with the Smart line, position us to face the pandemic emergency with highly innovative solutions.
Our products help facilitate the diagnosis of respiratory diseases with Spirometers, Pulse Oximeters, Integrated Multi–Sensor Systems and Software for PC, Tablets and Smartphones suitable for every platform: Windows, Mac, iOS and Android.
Our latest generation of software uses algorithms based on artificial intelligence criteria paired with an expert system that allows doctors to achieve the best patient compliance when performing spirometry tests.
Though it is best known for its spirometers, MIR is a Smart Company that offers solutions for the diagnosis of respiratory diseases in many different settings:
– professional diagnostic
– primary care
– personal care
– clinical trials
Our instruments are also available in OEM versions and the software is supported by SDK (Software Development Kit) and related API.
Behind our innovative products are numerous patents and trademarks; many of our products have also received prestigious international awards for their design.
We collaborate with researchers from all over the world with whom we have completed hundreds of projects utilizing our exclusive technology.
We are truly passionate about the innovative offerings that we bring to market and strive daily to exceed our customers’ demand for competence and excellence through considerable and continuous investment in research and technological development!
Believe us: the products we are designing today will be more exciting and more innovative than anything you have seen before.
MIR is a global medical device and software company founded in 1993, and today is present in more than 100 countries worldwide.
For more than 25 years, we have been internationally recognized for our numerous innovations and advancements in three different market areas: Spirometry, Oximetry and Remote Patient Monitoring.
Switch to MIR! The products we are designing today, will be more exciting and more innovative than anything you have seen before.
MIR solutions for HealthCare are CE Marked and FDA cleared.
A wide range of local import certifications have also been accomplished, making MIR products available in your country.
The complete list of Local import Certifications is available for you to check.
Not yet available in your country? Let us know and we'll support you in this.